Login / Signup

Quality of adverse event reporting in phase III randomized controlled trials of breast and colorectal cancer: A systematic review.

Adam S KomorowskiHelen J MacKayRossanna C Pezo
Published in: Cancer medicine (2020)
CRD42019140673.
Keyphrases
  • phase iii
  • open label
  • randomized controlled trial
  • adverse drug
  • clinical trial
  • double blind
  • phase ii
  • placebo controlled
  • study protocol
  • quality improvement
  • emergency department
  • meta analyses
  • drug induced